Effect of Time Delay and Syringe Surface Area on Blood Gas Samples Analysis
1 other identifier
observational
45
1 country
1
Brief Summary
To detect the effect of time delay and syringe surface area on the oxygen tension (PaO2), oxyhaemoglobin saturation (SaO2), acidity (pH), and carbon dioxide tension (PaCO2) in both arterial and venous blood gas outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2019
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 30, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2020
CompletedFirst Submitted
Initial submission to the registry
July 18, 2024
CompletedFirst Posted
Study publicly available on registry
July 26, 2024
CompletedAugust 9, 2024
August 1, 2024
1 year
July 18, 2024
August 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To detect the effect of time delay and syringe surface area on the oxygen tension (PaO2) arterial and venous blood gas outcomes.
PaO2 by mmhg arterial and venous samples To detect the effect of time delay and syringe surface area on SO2 in arterial and venous samples To detect the effect of time delay and syringe surface area on other parameters of blood gases e.g. PH,CO2
1 hour
Secondary Outcomes (1)
effect of delay on analysis oxyhaemoglobin saturation (SaO2) acidity (pH) carbon dioxide tension (PaCO2)
60 minutes
Eligibility Criteria
Critically ill-patients, and intraoperative patients who aged above 18 years.
You may qualify if:
- Critically ill-patients, and intraoperative patients who aged above 18 years.
You may not qualify if:
- Patients with haematological diseases e.g. sickle cell anaemia
- burn patients with risk of carbon monoxide poisoning
- ARDS
- pulmonary oedema
- samples that were clotted
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Helwan Universitylead
- Theodor Bilharz Research Institutecollaborator
Study Sites (1)
Theodor Bilharz Research Institute
Cairo, 3357, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adel A hassan, Md
Helwan University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anaesthesia, intensive care and pain management
Study Record Dates
First Submitted
July 18, 2024
First Posted
July 26, 2024
Study Start
July 30, 2019
Primary Completion
July 30, 2020
Study Completion
July 30, 2020
Last Updated
August 9, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- after the end of the study for one year
- Access Criteria
- The data will be available upon a reasonable request from the corresponding author.
The data will be available upon a reasonable request from the corresponding author after the end of study for one year.